Of the 25 non-synonymous variants found within the two discovery cases of the current analysis, NOTCH2 and MYD88 were already known to be recurrently mutated in SMZL [11–14, 23–25]. This evidence concerns the gene MYD88 and splenic marginal zone lymphoma.